DMRA

Damora Therapeutics, Inc. DMRA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$1.67B total
FMR LLC
$240.15M+2.1%
Fairmount Funds Management LLC
$226.63M0.0%
Avoro Capital Advisors LLC
$98.40M0.0%
VR Adviser, LLC
$93.73M0.0%
BlackRock, Inc.
$82.25M+1321.6%
FCPM III SERVICES B.V.
$63.49M0.0%
RA CAPITAL MANAGEMENT, L.P.
$62.42M0.0%
VIKING GLOBAL INVESTORS LP
$60.11M0.0%
Jupiter Topco LLC
$59.28M--
Remedium Capital Partners, LLC
$53.20M0.0%
Commodore Capital LP
$50.43M0.0%
JPMORGAN CHASE & CO
$49.85MNew
BRAIDWELL LP
$42.15M+81.1%
Bellevue Group AG
$42.11M-29.6%
STATE STREET CORP
$40.20M+740.3%
a16z Capital Management, L.L.C.
$32.15M0.0%
BALYASNY ASSET MANAGEMENT L.P.
$31.97M-15.1%
PERCEPTIVE ADVISORS LLC
$31.81M0.0%
WELLINGTON MANAGEMENT GROUP LLP
$27.52M0.0%
Blackstone Inc.
$26.09M+99.2%
Cormorant Asset Management, LP
$26.01M-34.4%
GEODE CAPITAL MANAGEMENT, LLC
$25.11M+300.4%
Siren, L.L.C.
$23.41M0.0%
UBS Group AG
$21.86M+423.8%
Vestal Point Capital, LP
$14.96M-4.2%
See all 101 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/DMRA

Earnings Per Share

13fpro.ai/company/DMRA

Loading ratio trend…

DMRA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Damora Therapeutics, Inc. (DMRA): stock profile, AI score and financials

Damora Therapeutics, Inc. (DMRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. DMRA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of DMRA by reported 13-F value include FMR, Fairmount Funds Management, Avoro Capital Advisors, based on the most recent SEC filings. DMRA trades on the Nasdaq exchange and files with the SEC under CIK 1800315. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate DMRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Damora Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1800315 →